Premaitha Health (AIM: NIPT) is an innovative molecular diagnostics company employing the latest advances in DNA analysis technology to develop tests for non-invasive prenatal screening (NIPT) and other applications. Premaitha’s flagship product, the IONA® test is the first non-invasive in vitro diagnostic CE marked product for prenatal screening enabling clinical laboratories to offer a regulated NIPT in-house.
UK Investor Show
Recognised as the UK’s top one day event for those serious about making money from shares, UK Investor is owned by the Wray family.
@JMHDeakin Send an email to email@example.com with your details and we'll refund. The discount code does not ask for a credit card number.